Loss of Heterozygosity for Chromosomes 1 or 14 Defines Subsets of Advanced Neuroblastomas

Cancer Research

Volumn 52, Issue 7, 1992, Pages 1780-1785

  Look, A Thomas ^e   Vogelstein, Bert ^c   Cavenee, Webster K ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d POG Statistical Office   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADVANCED CANCER; ARTICLE; CHILD; CHROMOSOME 14Q; CHROMOSOME 1P; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, MYC; HETEROZYGOTE; HUMAN; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NEUROBLASTOMA; PLOIDIES; PROGNOSIS; RESTRICTION MAPPING; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026769255     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Brodeur, G. M., Green, A. A., Hayes, F. A., Williams, K. J., Williams, D. L., and Tsiatis, A. A. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res., 41:4678-4686,1981.
2. Gilbert, F., Feder, M., Balaban, G., Brangman, D., Lurie, D., Podolsky, R., Rinaldt, V., Vinikoor, N., and Weisband, J. Human neuroblastomas and abnormalities of chromosome 1 and 17. Cancer Res., 44: 5444-5449,1984.
3. Brodeur, G. M., and Fong, C. T. Molecular biology and genetics of human neuroblastoma. Cancer Genet. Cytogenet., 41:153-174, 1989.
4. Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., and Brodeur, G. M. Loss of heterozygosity for chromosome Ip in human neuroblastomas: correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA, 86:3753-3757, 1989.
5. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington, DC), 224: 1121-1124, 1984.
6. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116,1985.
7. Brodeur, G. M. Neuroblastoma: clinical applications of molecular parameters. Brain Pathol., 1: 47-54,1990.
8. Tsuda, T., Obara, M., Hirano, H., Gotoh, S., Kubomura, S., Higashi, K., Kuroiwa, A., Nakagawara, A., Nagahara, N., and Shimizu, K. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer (Phila.), 60:820-826,1987.
9. Slave, I., Ellenbogen, R., Jung, W-H., Vawter, G. F., Kretschmar, C., Grier, H., and Korf, B. R. Myc gene amplification and expression in primary human neuroblastoma. Cancer Res., 50: 1459-1463, 1990.
10. Bourhis, J., DeVathaire, F., Wilson, G. D., Hartmann, O., Terrier-Lacombe, M. J., Boccon-Gibod, L., McNally, N. J., Lemerle, J., Riou, G., and Bernard, J. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res., 51: 33-36, 1991.
11. Franke, F., Rudolph, B., Christiansen, H., Harbott, J., and Lampert, F. Tumour karyotype may be important in the prognosis of human neuroblastoma. J. Cancer Res. Clin. Oncol., III: 266-272,1986.
12. Kaneko, Y., Kanda, N., Maseki, N., Sakurai, M., Tsuchida, Y., Takeda, T., Okabe, I., and Sakurai, M. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res., 47: 311-318,1987.
13. Christiansen, H., and Lampert, F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br. J. Cancer, 57: 121-126,1988.
14. Hayashi, Y., Kanda, N., Inaba, T., Hanada, R., Nagahara, N., Muchi, H., and Yamamoto, K. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer (Phila.), 63:126-132,1989.
15. Look, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., and Green, A. A. Cellular DNA content as predictor of response to chemotherapy in infants with unresectable neuroblastoma. N. Engl. J. Med., 311:231-235,1984.
16. Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. L., and Brodeur, G. M. Clinical relevance of tumor cell ploidy and gene amplification in childhood neuroblastoma: a Pediatric Oncology Group Study. J. Clin. Oncol., 9:581-591,1991.
17. Gansler, T., Chatten, J., Varello, M., Bunin, G. R., and Atkinson, B. Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome. Cancer (Phila.), 58:2453-2458,1986.
18. Oppedal, B. R., Storm-Mathisen, L., Lie, S. O., and Brandtzaeg, P. Prognostic factors in neuroblastoma. Clinical, histopathologic, immunohistochemical features and DNA ploidy in relation to prognosis. Cancer (Phila.), 62: 772-780,1988.
19. Taylor, S. R., Blatt, J., Constantino, J. P., Roederer, M., and Murphy, R. F. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study. Cancer (Phila.), 62:749-754,1988.
20. Cohn, S. L., Rademaker, A. W., Salwen, H. R., Franklin, W. A., Gonzales-Crussi, F., Rosen, S. T., and Bauer, K. D. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am. J. Pathol., 136:1043-1052,1990.
21. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigen-esis. Cell, 61: 759-761, 1990.
22. Suzuki, T., Yokota, J., Mugishima, H., Okabe, I., Ookuni, M., Sugimura, T., and Terada, M. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res., 49: 1095-1098,1989.
23. Srivatsan, E. S., Murali, V., and Seeger, R. C. Loss of heterozygosity for alleles on chromosome 1 Iq and 14q in neuroblastoma. Prog. Clin. Biol. Res., 566:91-98,1991.
24. Biedler, J. L., Ross, R. A., Shanske, S., and Spengler, B. A. Human neuroblastoma cytogenetics: search for significance of homogeneously staining regions and double minute chromosomes. Prog. Cancer Res. Ther., 12: 81-96, 1980.
25. Nitschke, R., Smith, E. L., Shochat, S., Altshuler, G., Travers, H., Shuster, J. J., Hayes, F. A., Patterson, R., and McWilliams, N. Localized neuroblastoma treated by surgery-A Pediatric Oncology Group Study. J. Clin. Oncol., 6: 1271-1279,1988.
26. Brodeur, G. M. Neuroblastoma and other peripheral neuroectodermal tumors. In: D. J. Fembach and T. J. Vietti (eds.). Clinical Pediatric Oncology, Ed. 4, pp. 337-364. St. Louis: Mosby Year Book, 1991.
27. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., White, R., and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Washington, DC), 244: 217-221,1989.
28. Seeger, R. C., Wada, R., Brodeur, G. M., Moss, T. J., Bjork, R. L., Sousa, L., and Slamon, D. J. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog. Clin. Biol. Res., 271:41-49,1988.
29. Christiansen, H., and Lampert, F. Tumor cytogenetics and prognosis in neuroblastoma. Monatsschr. Kinderheilkd., 757:666-671, 1989.
30. Brodeur, G. M., Sekhon, G. S., and Goldstein, M. N. Chromosomal aberrations in human neuroblastomas. Cancer (Phila.), 40:2256-2263, 1977.
31. Weith, A., Martinsson, T., Cziepluch, C., Bruderlein, S., Amler, L. C., and Berthold, F. Neuroblastoma consensus deletion maps to lp36.1-2. Genes Chromosomes Cancer, 1: 159-166,1989.
32. Bader, S., Fasching, C., Brodeur, G. M., and Stanbridge, E. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth & Differ., 2: 245-255, 1991.